Form 4 Tracker
Steven P. Coen

Chief Financial Officer · 8 filings · Latest: Oct 5, 2026

Ginkgo Bioworks Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
DNA
Steven P. CoenChief Financial OfficerOct 5, 2026
Sale
$15.002,403$36.0K49,448
DNA
Coen Steven P.—Oct 5, 2026
Proposed Sale
$15.002,403$36.0K—
DNA
Steven P. CoenChief Financial OfficerAug 24, 2026
Sale
$6.98330$2.3K51,851
DNA
Steven P. CoenChief Financial OfficerAug 21, 2026
Option Exercise
—743—52,181
DNA
Coen Steven P.—Aug 24, 2026
Proposed Sale
$6.98330$2.3K—
DNA
Steven P. CoenChief Financial OfficerJul 17, 2026
Sale
$7.90752$5.9K51,438
DNA
Steven P. CoenChief Financial OfficerJul 16, 2026
Option Exercise
—1,486—52,190
DNA
Coen Steven P.—Jul 17, 2026
Proposed Sale
$7.90752$5.9K—
DNA
Steven P. CoenChief Financial OfficerMay 22, 2026
Sale
$8.33307$2.6K50,704
DNA
Steven P. CoenChief Financial OfficerMay 21, 2026
Option Exercise
—743—51,011
DNA
Coen Steven P.—May 22, 2026
Proposed Sale
$8.33307$2.6K—
DNA
Steven P. CoenChief Financial OfficerApr 17, 2026
Sale
$7.95324$2.6K50,268
DNA
Steven P. CoenChief Financial OfficerApr 16, 2026
Option Exercise
—743—50,592
DNA
Coen Steven P.—Apr 17, 2026
Proposed Sale
$7.95324$2.6K—
DNA
Steven P. CoenChief Financial OfficerApr 13, 2026
Sale
$6.4133,171$212.8K49,849
DNA
Steven P. CoenChief Financial OfficerApr 10, 2026
Option Exercise
—73,921—83,020
DNA
Coen Steven P.—Apr 13, 2026
Proposed Sale
$6.4133,171$212.8K—
DNA
Steven P. CoenChief Financial OfficerMar 16, 2026
Sale
$6.74708$4.8K9,099
DNA
Steven P. CoenChief Financial OfficerMar 13, 2026
Option Exercise
—1,486—9,807
DNA
Coen Steven P.—Mar 16, 2026
Proposed Sale
$6.74708$4.8K—

Page 1 of 2

Next →